Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 161

1.

Interleukin 8 as predictive factor for response to chemotherapy in colorectal cancer patients.

Burz C, Bojan A, Balacescu L, Pop VV, Silaghi C, Lupan I, Aldea C, Sur D, Samasca G, Cainap C, Chiorean B.

Acta Clin Belg. 2019 Oct 14:1-6. doi: 10.1080/17843286.2019.1680133. [Epub ahead of print]

PMID:
31610752
2.

Re-evaluating herd protection by Vi typhoid vaccine in a cluster randomized trial.

Ali M, Sur D, Kanungo S, Qadri F, Kim DR, Islam T, Im J, Ahmmed F, Chon Y, Khan AI, Zaman K, Marks F, Dutta S, Bhattacharya SK, Clemens JD.

Int Health. 2019 Oct 14. pii: ihz069. doi: 10.1093/inthealth/ihz069. [Epub ahead of print]

PMID:
31608962
3.

MiRNAs roles in the diagnosis, prognosis and treatment of colorectal cancer.

Sur DG, Colceriu M, Sur G, Aldea C, Silaghi C, Samasca G, Lupan I, Căinap C, Burz C, Irimie A.

Expert Rev Proteomics. 2019 Oct;16(10):851-856. doi: 10.1080/14789450.2019.1659732. Epub 2019 Aug 29.

PMID:
31446809
4.

Trials of the killed oral cholera vaccine (Shanchol) in India and Bangladesh: Lessons learned and way forward.

Islam MT, Chowdhury F, Qadri F, Sur D, Ganguly NK.

Vaccine. 2019 Jul 10. pii: S0264-410X(19)30870-9. doi: 10.1016/j.vaccine.2019.06.082. [Epub ahead of print]

5.

Welcoming Feedback: Using Family Experience to Design a Pediatric Weight Management Program.

Green J, Wills A, Mansfield E, Sur D, Zenlea IS.

J Patient Exp. 2019 Jun;6(2):142-149. doi: 10.1177/2374373518786505. Epub 2018 Jul 5.

6.

The incidence, aetiology, and adverse clinical consequences of less severe diarrhoeal episodes among infants and children residing in low-income and middle-income countries: a 12-month case-control study as a follow-on to the Global Enteric Multicenter Study (GEMS).

Kotloff KL, Nasrin D, Blackwelder WC, Wu Y, Farag T, Panchalingham S, Sow SO, Sur D, Zaidi AKM, Faruque ASG, Saha D, Alonso PL, Tamboura B, Sanogo D, Onwuchekwa U, Manna B, Ramamurthy T, Kanungo S, Ahmed S, Qureshi S, Quadri F, Hossain A, Das SK, Antonio M, Hossain MJ, Mandomando I, Acácio S, Biswas K, Tennant SM, Verweij JJ, Sommerfelt H, Nataro JP, Robins-Browne RM, Levine MM.

Lancet Glob Health. 2019 May;7(5):e568-e584. doi: 10.1016/S2214-109X(19)30076-2.

7.

Diagnosis of gluten-related disorders: A new and challenging public health problem.

Sur LM, Dascăl L, Sur G, Sur DG, Floca E, Aldea C, Lupan I, Samasca G.

Autoimmun Rev. 2019 Jun;18(6):645-646. doi: 10.1016/j.autrev.2019.02.008. Epub 2019 Apr 5. No abstract available.

PMID:
30959219
8.

Colorectal cancer: evolution of screening strategies.

Sur D, Colceriu M, Sur G, Floca E, Dascal L, Irimie A.

Med Pharm Rep. 2019 Jan;92(1):21-24. doi: 10.15386/cjmed-1104. Epub 2019 Jan 15. Review.

9.

Liquid biopsy challenge and hope in colorectal cancer.

Burz C, Rosca A, Pop VV, Buiga R, Aldea C, Samasca G, Silaghi C, Sur D, Lupan I, Pricopie A.

Expert Rev Mol Diagn. 2019 Apr;19(4):341-348. doi: 10.1080/14737159.2019.1597708. Epub 2019 Apr 4.

PMID:
30943811
10.

Cholera prevention and control in Asian countries.

Ahmed MU, Baquilod M, Deola C, Tu ND, Anh DD, Grasso C, Gautam A, Hamzah WM, Heng S, Iamsirithaworn S, Kadim M, Kar SK, Le Thi Quynh M, Lopez AL, Lynch J, Memon I, Mengel M, Long VN, Pandey BD, Quadri F, Saadatian-Elahi M, Gupta SS, Sultan A, Sur D, Tan DQ, Ha HTT, Hein NT, Lan PT, Upreti SR, Endtz H, Ganguly NK, Legros D, Picot V, Nair GB.

BMC Proc. 2018 Dec 7;12(Suppl 13):62. doi: 10.1186/s12919-018-0158-1. eCollection 2018.

11.

Colonization factors among enterotoxigenic Escherichia coli isolates from children with moderate-to-severe diarrhea and from matched controls in the Global Enteric Multicenter Study (GEMS).

Vidal RM, Muhsen K, Tennant SM, Svennerholm AM, Sow SO, Sur D, Zaidi AKM, Faruque ASG, Saha D, Adegbola R, Hossain MJ, Alonso PL, Breiman RF, Bassat Q, Tamboura B, Sanogo D, Onwuchekwa U, Manna B, Ramamurthy T, Kanungo S, Ahmed S, Qureshi S, Quadri F, Hossain A, Das SK, Antonio M, Mandomando I, Nhampossa T, Acácio S, Omore R, Ochieng JB, Oundo JO, Mintz ED, O'Reilly CE, Berkeley LY, Livio S, Panchalingam S, Nasrin D, Farag TH, Wu Y, Sommerfelt H, Robins-Browne RM, Del Canto F, Hazen TH, Rasko DA, Kotloff KL, Nataro JP, Levine MM.

PLoS Negl Trop Dis. 2019 Jan 4;13(1):e0007037. doi: 10.1371/journal.pntd.0007037. eCollection 2019 Jan.

12.

PotentialNet for Molecular Property Prediction.

Feinberg EN, Sur D, Wu Z, Husic BE, Mai H, Li Y, Sun S, Yang J, Ramsundar B, Pande VS.

ACS Cent Sci. 2018 Nov 28;4(11):1520-1530. doi: 10.1021/acscentsci.8b00507. Epub 2018 Nov 2.

13.

The Impact of miRNA in Colorectal Cancer Progression and Its Liver Metastases.

Balacescu O, Sur D, Cainap C, Visan S, Cruceriu D, Manzat-Saplacan R, Muresan MS, Balacescu L, Lisencu C, Irimie A.

Int J Mol Sci. 2018 Nov 22;19(12). pii: E3711. doi: 10.3390/ijms19123711. Review.

14.

Education programs for medical psychiatry collaborative care: A scoping review.

Shen N, Sockalingam S, Charow R, Bailey S, Bernier T, Freeland A, Hawa A, Sur D, Wiljer D.

Gen Hosp Psychiatry. 2018 Nov - Dec;55:51-59. doi: 10.1016/j.genhosppsych.2018.08.009. Epub 2018 Aug 30.

PMID:
30384004
15.

Role of zinc oxide nanoparticles for effluent treatment using Pseudomonas putida and Pseudomonas aureofaciens.

Sur DH, Mukhopadhyay M.

Bioprocess Biosyst Eng. 2019 Feb;42(2):187-198. doi: 10.1007/s00449-018-2024-y. Epub 2018 Oct 25.

PMID:
30362046
16.

A Retrospective Review of Hospital-Based Data on Enteric Fever in India, 2014-2015.

Sur D, Barkume C, Mukhopadhyay B, Date K, Ganguly NK, Garrett D.

J Infect Dis. 2018 Nov 10;218(suppl_4):S206-S213. doi: 10.1093/infdis/jiy502.

17.

Phase I of the Surveillance for Enteric Fever in Asia Project (SEAP): An Overview and Lessons Learned.

Barkume C, Date K, Saha SK, Qamar FN, Sur D, Andrews JR, Luby SP, Khan MI, Freeman A, Yousafzai MT, Garrett D.

J Infect Dis. 2018 Nov 10;218(suppl_4):S188-S194. doi: 10.1093/infdis/jiy522. Erratum in: J Infect Dis. 2019 Jan 9;219(3):509. J Infect Dis. 2019 Apr 16;219(9):1514.

18.

Chronic Nonallergic Rhinitis.

Sur DKC, Plesa ML.

Am Fam Physician. 2018 Aug 1;98(3):171-176.

19.

Polyautoimmunity - The missing ingredient.

Samasca G, Ajay R, Sur D, Aldea C, Sur L, Floca E, Sur G, Lupan I, Torsten M, Aaron L.

Autoimmun Rev. 2018 Aug;17(8):840-841. doi: 10.1016/j.autrev.2018.03.008. Epub 2018 Jun 7. No abstract available.

PMID:
29885545
20.

Antinuclear Antibodies: Marker of Diagnosis and Evolution in Autoimmune Diseases.

Sur LM, Floca E, Sur DG, Colceriu MC, Samasca G, Sur G.

Lab Med. 2018 Jul 5;49(3):e62-e73. doi: 10.1093/labmed/lmy024. Review.

PMID:
29868860
21.

Antibody secreting B cells and plasma antibody response to rotavirus vaccination in infants from Kolkata India.

Sinha A, Kanungo S, Kim DR, Manna B, Song M, Park JY, Haldar B, Sharma P, Mallick AH, Kim SA, Babji S, Sur D, Kang G, Ali M, Petri WA Jr, Wierzba TF, Czerkinsky C, Nandy RK, Dey A.

Heliyon. 2018 Feb 1;4(1):e00519. doi: 10.1016/j.heliyon.2018.e00519. eCollection 2018 Jan.

22.

Process parametric study for COD removal of electroplating industry effluent.

Sur DH, Mukhopadhyay M.

3 Biotech. 2018 Feb;8(2):84. doi: 10.1007/s13205-017-1059-0. Epub 2018 Jan 17.

23.

Detection of the LINE-1 retrotransposon RNA-binding protein ORF1p in different anatomical regions of the human brain.

Sur D, Kustwar RK, Budania S, Mahadevan A, Hancks DC, Yadav V, Shankar SK, Mandal PK.

Mob DNA. 2017 Nov 22;8:17. doi: 10.1186/s13100-017-0101-4. eCollection 2017.

24.

Use of oral cholera vaccine as a vaccine probe to define the geographical dimensions of person-to-person transmission of cholera.

Ali M, Kim DR, Kanungo S, Sur D, Manna B, Digilio L, Dutta S, Marks F, Bhattacharya SK, Clemens J.

Int J Infect Dis. 2018 Jan;66:90-95. doi: 10.1016/j.ijid.2017.11.020. Epub 2017 Nov 22.

25.

Direct Detection of Shigella in Stool Specimens by Use of a Metagenomic Approach.

Liu J, Almeida M, Kabir F, Shakoor S, Qureshi S, Zaidi A, Li S, Tamboura B, Sow SO, Mandomando I, Alonso PL, Ramamurthy T, Sur D, Kotloff K, Nataro J, Levine MM, Stine OC, Houpt E.

J Clin Microbiol. 2018 Jan 24;56(2). pii: e01374-17. doi: 10.1128/JCM.01374-17. Print 2018 Feb.

26.

Identification of burden hotspots and risk factors for cholera in India: An observational study.

Ali M, Sen Gupta S, Arora N, Khasnobis P, Venkatesh S, Sur D, Nair GB, Sack DA, Ganguly NK.

PLoS One. 2017 Aug 24;12(8):e0183100. doi: 10.1371/journal.pone.0183100. eCollection 2017.

27.

COD reduction of textile effluent in three-phase fluidized bed bioreactor using Pseudomonas aureofaciens and Escherichia coli.

Sur DH, Mukhopadhyay M.

3 Biotech. 2017 Jun;7(2):141. doi: 10.1007/s13205-017-0771-0. Epub 2017 Jun 8.

28.

Comparison of IPV to tOPV week 39 boost of primary OPV vaccination in Indian infants: an open labelled randomized controlled trial.

Kanungo S, Kim DR, Haldar B, Snider C, Nalavade U, Kim SA, Park JY, Sinha A, Mallick AH, Manna B, Sur D, Nandy RK, Deshpande JM, Czerkinsky C, Wierzba TF, Petri WA Jr, Ali M, Dey A.

Heliyon. 2017 Jan 9;3(1):e00223. doi: 10.1016/j.heliyon.2016.e00223. eCollection 2017 Jan.

29.

Retrospective Analysis of Serotype Switching of Vibrio cholerae O1 in a Cholera Endemic Region Shows It Is a Non-random Process.

Karlsson SL, Thomson N, Mutreja A, Connor T, Sur D, Ali M, Clemens J, Dougan G, Holmgren J, Lebens M.

PLoS Negl Trop Dis. 2016 Oct 5;10(10):e0005044. doi: 10.1371/journal.pntd.0005044. eCollection 2016 Oct.

30.

Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study.

Liu J, Platts-Mills JA, Juma J, Kabir F, Nkeze J, Okoi C, Operario DJ, Uddin J, Ahmed S, Alonso PL, Antonio M, Becker SM, Blackwelder WC, Breiman RF, Faruque AS, Fields B, Gratz J, Haque R, Hossain A, Hossain MJ, Jarju S, Qamar F, Iqbal NT, Kwambana B, Mandomando I, McMurry TL, Ochieng C, Ochieng JB, Ochieng M, Onyango C, Panchalingam S, Kalam A, Aziz F, Qureshi S, Ramamurthy T, Roberts JH, Saha D, Sow SO, Stroup SE, Sur D, Tamboura B, Taniuchi M, Tennant SM, Toema D, Wu Y, Zaidi A, Nataro JP, Kotloff KL, Levine MM, Houpt ER.

Lancet. 2016 Sep 24;388(10051):1291-301. doi: 10.1016/S0140-6736(16)31529-X.

31.

Potential for Controlling Cholera Using a Ring Vaccination Strategy: Re-analysis of Data from a Cluster-Randomized Clinical Trial.

Ali M, Debes AK, Luquero FJ, Kim DR, Park JY, Digilio L, Manna B, Kanungo S, Dutta S, Sur D, Bhattacharya SK, Sack DA.

PLoS Med. 2016 Sep 13;13(9):e1002120. doi: 10.1371/journal.pmed.1002120. eCollection 2016 Sep.

32.

Challenges in new vaccine introduction in a national program in India.

Sur D.

Indian J Public Health. 2016 Jul-Sep;60(3):171-5. doi: 10.4103/0019-557X.188995.

33.

Aeromonas-Associated Diarrhea in Children Under 5 Years: The GEMS Experience.

Qamar FN, Nisar MI, Quadri F, Shakoor S, Sow SO, Nasrin D, Blackwelder WC, Wu Y, Farag T, Panchalingham S, Sur D, Qureshi S, Faruque AS, Saha D, Alonso PL, Breiman RF, Bassat Q, Tamboura B, Ramamurthy T, Kanungo S, Ahmed S, Hossain A, Das SK, Antonio M, Hossain MJ, Mandomando I, Tennant SM, Kotloff KL, Levine MM, Zaidi AK.

Am J Trop Med Hyg. 2016 Oct 5;95(4):774-780. Epub 2016 Aug 15.

34.

Why is the oral cholera vaccine not considered an option for prevention of cholera in India? Analysis of possible reasons.

Gupta SS, Bharati K, Sur D, Khera A, Ganguly NK, Nair GB.

Indian J Med Res. 2016 May;143(5):545-51. doi: 10.4103/0971-5916.187102. No abstract available.

35.

The Burden of Cryptosporidium Diarrheal Disease among Children < 24 Months of Age in Moderate/High Mortality Regions of Sub-Saharan Africa and South Asia, Utilizing Data from the Global Enteric Multicenter Study (GEMS).

Sow SO, Muhsen K, Nasrin D, Blackwelder WC, Wu Y, Farag TH, Panchalingam S, Sur D, Zaidi AK, Faruque AS, Saha D, Adegbola R, Alonso PL, Breiman RF, Bassat Q, Tamboura B, Sanogo D, Onwuchekwa U, Manna B, Ramamurthy T, Kanungo S, Ahmed S, Qureshi S, Quadri F, Hossain A, Das SK, Antonio M, Hossain MJ, Mandomando I, Nhampossa T, Acácio S, Omore R, Oundo JO, Ochieng JB, Mintz ED, O'Reilly CE, Berkeley LY, Livio S, Tennant SM, Sommerfelt H, Nataro JP, Ziv-Baran T, Robins-Browne RM, Mishcherkin V, Zhang J, Liu J, Houpt ER, Kotloff KL, Levine MM.

PLoS Negl Trop Dis. 2016 May 24;10(5):e0004729. doi: 10.1371/journal.pntd.0004729. eCollection 2016 May.

36.

Sanitation and Hygiene-Specific Risk Factors for Moderate-to-Severe Diarrhea in Young Children in the Global Enteric Multicenter Study, 2007-2011: Case-Control Study.

Baker KK, O'Reilly CE, Levine MM, Kotloff KL, Nataro JP, Ayers TL, Farag TH, Nasrin D, Blackwelder WC, Wu Y, Alonso PL, Breiman RF, Omore R, Faruque AS, Das SK, Ahmed S, Saha D, Sow SO, Sur D, Zaidi AK, Quadri F, Mintz ED.

PLoS Med. 2016 May 3;13(5):e1002010. doi: 10.1371/journal.pmed.1002010. eCollection 2016 May.

37.
38.

Treatment of Allergic Rhinitis.

Sur DK, Plesa ML.

Am Fam Physician. 2015 Dec 1;92(11):985-92.

39.

Use of the data system for field management of a clinical study conducted in Kolkata, India.

Park JY, Kim DR, Haldar B, Mallick AH, Kim SA, Dey A, Nandy RK, Paul DK, Choudhury S, Sahoo S, Wierzba TF, Sur D, Kanungo S, Ali M, Manna B.

BMC Res Notes. 2016 Jan 9;9:20. doi: 10.1186/s13104-015-1767-7.

40.

Validity of the estimates of oral cholera vaccine effectiveness derived from the test-negative design.

Ali M, You YA, Sur D, Kanungo S, Kim DR, Deen J, Lopez AL, Wierzba TF, Bhattacharya SK, Clemens JD.

Vaccine. 2016 Jan 20;34(4):479-485. doi: 10.1016/j.vaccine.2015.12.004. Epub 2015 Dec 17.

PMID:
26707378
41.

Assessing different measures of population-level vaccine protection using a case-control study.

Ali M, You YA, Kanungo S, Manna B, Deen JL, Lopez AL, Wierzba TF, Bhattacharya SK, Sur D, Clemens JD.

Vaccine. 2015 Nov 27;33(48):6878-83. doi: 10.1016/j.vaccine.2015.07.045. Epub 2015 Sep 9.

PMID:
26364121
42.

Trials and tribulations of conducting interventional studies in urban slums of a developing country: Experiences from Kolkata, India.

Mahapatra T, Mahapatra S, Pal D, Saha J, Lopez A, Ali M, Bannerjee B, Manna B, Sur D, Bhattacharya S, Kanungo S.

Hum Vaccin Immunother. 2016;12(1):182-6. doi: 10.1080/21645515.2015.1066052. Epub 2015 Jul 29.

43.

An Open Label Non-inferiority Trial Assessing Vibriocidal Response of a Killed Bivalent Oral Cholera Vaccine Regimen following a Five Year Interval in Kolkata, India.

Kanungo S, Desai SN, Saha J, Nandy RK, Sinha A, Kim DR, Bannerjee B, Manna B, Yang JS, Ali M, Sur D, Wierzba TF.

PLoS Negl Trop Dis. 2015 May 29;9(5):e0003809. doi: 10.1371/journal.pntd.0003809. eCollection 2015 May.

44.

Predictors of rational management of diarrhea in an endemic setting: observation from India.

Mahapatra T, Mahapatra S, Banerjee B, Mahapatra U, Samanta S, Pal D, Datta Chakraborty N, Manna B, Sur D, Kanungo S.

PLoS One. 2015 Apr 7;10(4):e0123479. doi: 10.1371/journal.pone.0123479. eCollection 2015.

45.

Flexibility of oral cholera vaccine dosing-a randomized controlled trial measuring immune responses following alternative vaccination schedules in a cholera hyper-endemic zone.

Kanungo S, Desai SN, Nandy RK, Bhattacharya MK, Kim DR, Sinha A, Mahapatra T, Yang JS, Lopez AL, Manna B, Bannerjee B, Ali M, Dhingra MS, Chandra AM, Clemens JD, Sur D, Wierzba TF.

PLoS Negl Trop Dis. 2015 Mar 12;9(3):e0003574. doi: 10.1371/journal.pntd.0003574. eCollection 2015 Mar.

46.

The relevance of inflammatory markers in metabolic syndrome.

Sur G, Floca E, Kudor-Szabadi L, Sur ML, Sur D, Samasca G.

Maedica (Buchar). 2014 Mar;9(1):15-8.

47.

Community based case-control study of rotavirus gastroenteritis among young children during 2008-2010 reveals vast genetic diversity and increased prevalence of G9 strains in Kolkata.

Mullick S, Mukherjee A, Ghosh S, Pazhani GP, Sur D, Manna B, Nataro JP, Levine MM, Ramamurthy T, Chawla-Sarkar M.

PLoS One. 2014 Nov 17;9(11):e112970. doi: 10.1371/journal.pone.0112970. eCollection 2014.

48.

Principles and nonpharmacologic management of obesity in adults.

Kushner RF, Sur DK.

J Fam Pract. 2014 Jul;63(7 Suppl):S15-20. Review. No abstract available.

PMID:
25198214
49.

Evaluation of safety and immunogenicity of a live attenuated tetravalent (G1-G4) Bovine-Human Reassortant Rotavirus vaccine (BRV-TV) in healthy Indian adults and infants.

Dhingra MS, Kundu R, Gupta M, Kanungo S, Ganguly N, Singh MP, Bhattacharya MK, Ghosh R, Kumar R, Sur D, Chadha SM, Saluja T.

Vaccine. 2014 Aug 11;32 Suppl 1:A117-23. doi: 10.1016/j.vaccine.2014.03.069.

50.

Safety and immunogenicity of a live oral recombinant cholera vaccine VA1.4: a randomized, placebo controlled trial in healthy adults in a cholera endemic area in Kolkata, India.

Kanungo S, Sen B, Ramamurthy T, Sur D, Manna B, Pazhani GP, Chowdhury G, Jhunjhunwala P, Nandy RK, Koley H, Bhattacharya MK, Gupta S, Goel G, Dey B, M T, Nair GB, Ghosh A, Mahalanabis D.

PLoS One. 2014 Jul 1;9(7):e99381. doi: 10.1371/journal.pone.0099381. eCollection 2014.

Supplemental Content

Support Center